Inventor · disambiguated record
Jaume Pons
Also filed as: PONS JAUME
58 granted patents·41 pending applications·1,121 citations·filing 2003–2025
99Inventor score
Files withALX ONCOLOGY INC31RINAT NEUROSCIENCE CORP16TEVA PHARMACEUTICALS INT GMBH10LABRYS BIOLOG INC8PFIZER6
Top patents by PatentIndex Score
99 records- 0198US8734802B1Methods of treating vasomotor symptoms using antibodiesLABRYS BIOLOG INC·Filed 2013·Granted May 27, 2014·54 cites·20 claims
- 0298US8597649B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2013·Granted Dec 3, 2013·51 cites·9 claims
- 0398US7655232B2Anti-NGF antibodies and methods using samePFIZER·Filed 2007·Granted Feb 2, 2010·60 cites·12 claims
- 0497US11208459B2Constructs having a SIRP-alpha domain or variant thereofALX ONCOLOGY INC·Filed 2020·Granted Dec 28, 2021·8 cites·54 claims
- 0597US10138303B2Heterodimeric proteins and methods for producing and purifying themRINAT NEUROSCIENCE CORP·Filed 2016·Granted Nov 27, 2018·14 cites·9 claims
- 0697US9884907B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 6, 2018·15 cites·18 claims
- 0797US9884908B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 6, 2018·15 cites·18 claims
- 0897US9346881B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2015·Granted May 24, 2016·16 cites·19 claims
- 0997US9340614B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2015·Granted May 17, 2016·16 cites·20 claims
- 1097US9266951B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2015·Granted Feb 23, 2016·23 cites·19 claims
- 1197US9115194B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameLABRYS BIOLOG INC·Filed 2014·Granted Aug 25, 2015·26 cites·20 claims
- 1297US8080243B2Isolated antibody which specifically binds to PCSK9LIANG HONG·Filed 2009·Granted Dec 20, 2011·139 cites·3 claims
- 1397US8007794B2Antagonist antibodies directed against calcitonin gene-related peptide and methods using sameRINAT NEUROSCIENCE CORP·Filed 2006·Granted Aug 30, 2011·51 cites·9 claims
- 1497US7449616B2Anti-NGF antibodies and methods using samePFIZER·Filed 2003·Granted Nov 11, 2008·93 cites·12 claims
- 1596US10696730B2Constructs having a SIRP-alpha domain or variant thereofALX ONCOLOGY INC·Filed 2018·Granted Jun 30, 2020·11 cites·54 claims
- 1696US10259859B2Constructs having a SIRP-α domain or variant thereofALX ONCOLOGY INC·Filed 2016·Granted Apr 16, 2019·35 cites·137 claims
- 1796US9890210B2Antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 13, 2018·11 cites·15 claims
- 1896US9890211B2Antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2017·Granted Feb 13, 2018·11 cites·15 claims
- 1996US9365648B1Methods of using anti-CGRP antagonist antibodiesLABRYS BIOLOG INC·Filed 2016·Granted Jun 14, 2016·16 cites·29 claims
- 2096US9328168B2Methods of using anti-CGRP antagonist antibodiesLABRYS BIOLOG INC·Filed 2015·Granted May 3, 2016·16 cites·30 claims
- 2196US8586045B2Methods of using anti-CGRP antagonist antibodiesZELLER JOERG·Filed 2011·Granted Nov 19, 2013·61 cites·31 claims
- 2296US8426363B2Method for reducing a level of LDL-cholesterol by an antibody that specifically binds to PCSK9LIANG HONG·Filed 2011·Granted Apr 23, 2013·58 cites·13 claims
- 2396US8399646B2Isolated nucleic acid encoding an antibody which specifically binds to PCSK9 and a host cell that produces the antibodyLIANG HONG·Filed 2011·Granted Mar 19, 2013·57 cites·14 claims
- 2495US9527926B2Heterodimeric proteins and methods for producing and purifying themHO WEI-HSIEN·Filed 2011·Granted Dec 27, 2016·44 cites·10 claims
- 2594US11242404B2Antibodies against signal-regulatory protein alpha and methods of useALX ONCOLOGY INC·Filed 2021·Granted Feb 8, 2022·3 cites·30 claims
- 2694US9676871B2Engineered polypeptide conjugates and methods for making thereof using transglutaminaseSTROP PAVEL·Filed 2011·Granted Jun 13, 2017·40 cites·19 claims
- 2794US8088384B2Anti-NGF antibodies and methods using samePONS JAUME·Filed 2009·Granted Jan 3, 2012·22 cites·11 claims
- 2894US7927594B2Antibodies directed against amyloid-beta peptideRINAT NEUROSCIENCE CORP·Filed 2005·Granted Apr 19, 2011·24 cites·21 claims
- 2994US7763250B2Antibodies directed against amyloid-beta peptide and nucleic acids encoding sameRINAT NEUROSCIENCE CORP·Filed 2006·Granted Jul 27, 2010·23 cites·29 claims
- 3093US12139529B2Antibody-peptide fusion proteins for treating amyloid disordersUNIV TENNESSEE RES FOUND·Filed 2023·Granted Nov 12, 2024·1 cites·9 claims
- 3193US11639376B2Constructs having a SIRP-α domain or variant thereofALX ONCOLOGY INC·Filed 2020·Granted May 2, 2023·3 cites·28 claims
- 3293US10329343B2Methods for treating headache using antagonist antibodies directed against calcitonin gene-related peptideTEVA PHARMACEUTICALS INT GMBH·Filed 2018·Granted Jun 25, 2019·5 cites·24 claims
- 3393US9029515B2Anti-PCSK9 antibodies with pH dependent antigen bindingPONS JAUME·Filed 2011·Granted May 12, 2015·43 cites·4 claims
- 3492US12098214B2Combination therapies for treating cancerALX ONCOLOGY INC·Filed 2022·Granted Sep 24, 2024·2 cites·6 claims
- 3592US11613564B2Methods of treating cancerALX ONCOLOGY INC·Filed 2020·Granted Mar 28, 2023·3 cites·7 claims
- 3691US11939393B2Antibodies against signal-regulatory protein alpha and methods of useALX ONCOLOGY INC·Filed 2022·Granted Mar 26, 2024·1 cites·24 claims
- 3791US11401338B2Antibodies against signal-regulatory protein alpha and methods of useALX ONCOLOGY INC·Filed 2017·Granted Aug 2, 2022·6 cites·37 claims
- 3890US2024158481A1Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using SameTEVA PHARMACEUTICALS INT GMBH·Filed 2023·Application pending·0 cites
- 3989US11795463B2Transglutaminase-mediated conjugationTALLAC THERAPEUTICS INC·Filed 2022·Granted Oct 24, 2023·1 cites·16 claims
- 4086US9175093B2PCSK9 antagonistsRINAT NEUROSCIENCE CORP·Filed 2013·Granted Nov 3, 2015·6 cites·11 claims
- 4185US11920136B2Transglutaminase-mediated conjugationTALLAC THERAPEUTICS INC·Filed 2021·Granted Mar 5, 2024·1 cites·47 claims
- 4285US7807165B2Antibodies directed against amyloid-beta peptide and methods using sameRINAT NEUROSCIENCE CORP·Filed 2005·Granted Oct 5, 2010·5 cites·68 claims
- 4385US2025011737A1Sirp-alpha variant constructs and uses thereofALX ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 4485US2024343778A1Constructs having a sirp-alpha domain or variant thereofALX ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 4584US11292850B2Antibodies against signal-regulatory protein α and methods of useALX ONCOLOGY INC·Filed 2019·Granted Apr 5, 2022·2 cites·62 claims
- 4683US9708398B2Anti-NGF antibodies and methods using sameRINAT NEUROSCIENCE CORP·Filed 2015·Granted Jul 18, 2017·2 cites·13 claims
- 4783US8338576B2Antibodies specific for DKK-1 and their usesPARALKAR VISHWAS MADHAV·Filed 2010·Granted Dec 25, 2012·12 cites·8 claims
- 4882US2024228574A9Methods of treating cancerALX ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 4981US11390689B2Heterodimeric proteins and methods for producing and purifying themRINAT NEUROSCIENCE CORP·Filed 2018·Granted Jul 19, 2022·1 cites·12 claims
- 5081US9212222B2Anti-NGF antibodies and methods using samePONS JAUME·Filed 2011·Granted Dec 15, 2015·3 cites·8 claims
Showing the top 50 of 99 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jaume Pons files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →